Victory Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22.8K | Sell |
23,202
-420
| -2% | -$413 | ﹤0.01% | 2436 |
|
2025
Q1 | $34K | Sell |
23,622
-149,461
| -86% | -$215K | ﹤0.01% | 2393 |
|
2024
Q4 | $381K | Buy |
173,083
+148,456
| +603% | +$327K | ﹤0.01% | 2097 |
|
2024
Q3 | $40.6K | Buy |
24,627
+2,417
| +11% | +$3.99K | ﹤0.01% | 2403 |
|
2024
Q2 | $49.3K | Sell |
22,210
-1,969
| -8% | -$4.37K | ﹤0.01% | 2370 |
|
2024
Q1 | $64.8K | Buy |
24,179
+8,981
| +59% | +$24.1K | ﹤0.01% | 2354 |
|
2023
Q4 | $45.4K | Buy |
15,198
+3,558
| +31% | +$10.6K | ﹤0.01% | 2448 |
|
2023
Q3 | $11.4K | Buy |
11,640
+1,372
| +13% | +$1.35K | ﹤0.01% | 2478 |
|
2023
Q2 | $14.3K | Buy |
+10,268
| New | +$14.3K | ﹤0.01% | 2470 |
|
2021
Q3 | – | Sell |
-17,390
| Closed | -$368K | – | 2794 |
|
2021
Q2 | $368K | Sell |
17,390
-689
| -4% | -$14.6K | ﹤0.01% | 2346 |
|
2021
Q1 | $507K | Sell |
18,079
-816
| -4% | -$22.9K | ﹤0.01% | 2199 |
|
2020
Q4 | $491K | Sell |
18,895
-929
| -5% | -$24.1K | ﹤0.01% | 2088 |
|
2020
Q3 | $737K | Sell |
19,824
-7,290
| -27% | -$271K | ﹤0.01% | 1831 |
|
2020
Q2 | $1.39M | Buy |
27,114
+138
| +0.5% | +$7.08K | ﹤0.01% | 1570 |
|
2020
Q1 | $850K | Buy |
26,976
+12,067
| +81% | +$380K | ﹤0.01% | 1906 |
|
2019
Q4 | $889K | Buy |
14,909
+707
| +5% | +$42.2K | ﹤0.01% | 1786 |
|
2019
Q3 | $521K | Buy |
14,202
+13,929
| +5,102% | +$511K | ﹤0.01% | 1868 |
|
2019
Q2 | $13K | Hold |
273
| – | – | ﹤0.01% | 1802 |
|
2019
Q1 | $11K | Hold |
273
| – | – | ﹤0.01% | 1762 |
|
2018
Q4 | $13K | Sell |
273
-52
| -16% | -$2.48K | ﹤0.01% | 1754 |
|
2018
Q3 | $14K | Buy |
325
+43
| +15% | +$1.85K | ﹤0.01% | 1777 |
|
2018
Q2 | $11K | Hold |
282
| – | – | ﹤0.01% | 1809 |
|
2018
Q1 | $20K | Hold |
282
| – | – | ﹤0.01% | 1790 |
|
2017
Q4 | $19K | Hold |
282
| – | – | ﹤0.01% | 1789 |
|
2017
Q3 | $14K | Hold |
282
| – | – | ﹤0.01% | 1794 |
|
2017
Q2 | $13K | Buy |
282
+5
| +2% | +$230 | ﹤0.01% | 1790 |
|
2017
Q1 | $10K | Hold |
277
| – | – | ﹤0.01% | 1789 |
|
2016
Q4 | $3K | Buy |
277
+17
| +7% | +$184 | ﹤0.01% | 1787 |
|
2016
Q3 | $4K | Buy |
260
+18
| +7% | +$277 | ﹤0.01% | 1772 |
|
2016
Q2 | $2K | Buy |
242
+5
| +2% | +$41 | ﹤0.01% | 1630 |
|
2016
Q1 | $4K | Buy |
237
+18
| +8% | +$304 | ﹤0.01% | 1656 |
|
2015
Q4 | $5K | Buy |
219
+12
| +6% | +$274 | ﹤0.01% | 1672 |
|
2015
Q3 | $5K | Buy |
207
+20
| +11% | +$483 | ﹤0.01% | 1613 |
|
2015
Q2 | $15K | Buy |
+187
| New | +$15K | ﹤0.01% | 1608 |
|